Oruka Therapeutics (ORKA) Misses Q2 EPS by 4c

Oruka Therapeutics (NASDAQ: ORKA) reported Q2 EPS of ($0.55), $0.04 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.

You May Also Be Interested In

• Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
• PayPal's CEO Is Planning to Go It Alone and Fix the Payments Giant - WSJ
• GSK to close German vaccine plant, 641 jobs at risk